CompletedNot Applicable

The Acceptability of the HPV Vaccine Postpartum and With Pediatric Well-child Visits: A Pilot Study

600 participantsStarted 2015-11

Plain-language summary

The purpose of this study is to determine if women would find it acceptable to receive the HPV vaccine postpartum at the pediatrician's office at the time of their child's two-month well- child visit when offered during the third trimester of pregnancy.

Who can participate

Age range18 Years – 26 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Pregnant women at 28 weeks of gestational age or greater Exclusion Criteria: * Primary language other than English or Spanish * Receipt of any prior doses of HPV vaccine.

What they're measuring

Acceptability of HPV vaccination

Timeframe: At time of enrollment

Trial details

NCT IDNCT02602626

SponsorUniversity of North Carolina, Chapel Hill

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2016-04

View on ClinicalTrials.gov More Vaccination trials